Severe bleeding diathesis as onset of light-chain amyloidosis: combined excessive fibrinolysis and acquired von Willebrand disease in a young patient

Our report shows a case of primary light-chain amyloidosis in a young patient that reflects the potential severity of bleeding diathesis associated with this plasma cell dyscrasia and the difficulty of diagnosis when only hemorrhagic manifestations are present at the onset of disease. The patient presented with recurrent and severe muscular bleeding secondary to associated acquired von Willebrand disease and fibrinolysis dysfunction. Treatment with bortezomib-cyclophosphamide and sequential hematopoietic stem cell transplantation solved coagulation alterations. On the basis of our case, we review previous reports and discuss the potential mechanism of dysfunction of coagulation in light-chain amyloidosis.

[1]  A. Dispenzieri,et al.  Coagulation Abnormalities in Light Chain Amyloidosis. , 2021, Mayo Clinic proceedings.

[2]  Shellaine R. Frazier,et al.  Evidence of both von Willebrand factor deposition and factor V deposition onto AL amyloid as the cause of a severe bleeding diathesis , 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[3]  Adrienne Lee,et al.  Acquired von Willebrand Syndrome Associated to Secondary IgM MGUS Emerging after Autologous Stem Cell Transplantation for AL Amyloidosis , 2017, Mediterranean journal of hematology and infectious diseases.

[4]  C. Bokemeyer,et al.  Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias , 2016, Annals of Hematology.

[5]  H. Mitsuya,et al.  Excessive fibrinolysis in AL-amyloidosis is induced by urokinae-type plasminogen activator from bone marrow plasma cells , 2009, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[6]  M. Skinner,et al.  Association of acquired von Willebrand syndrome with AL amyloidosis , 2007, American journal of hematology.

[7]  John D. Venable,et al.  Metalloendoprotease cleavage triggers gelsolin amyloidogenesis , 2005, The EMBO journal.

[8]  Judianne Davis,et al.  Amyloid β-Protein Stimulates the Expression of Urokinase-type Plasminogen Activator (uPA) and Its Receptor (uPAR) in Human Cerebrovascular Smooth Muscle Cells* , 2003, Journal of Biological Chemistry.

[9]  J. Lazarchick,et al.  Acquired von Willebrand's disease following bone marrow transplantation. , 1994, Annals of clinical and laboratory science.

[10]  R. Simms,et al.  Excessive fibrinolysis in amyloidosis associated with elevated plasma single-chain urokinase. , 1992, American journal of clinical pathology.